Overdenture as a Restorative Option for Hypocalcified-hypoplastic Amelogenesis imperfecta: A Case Report

2009 ◽  
Vol 10 (3) ◽  
pp. 67-73 ◽  
Author(s):  
Valentim Adelino Ricardo Baräo ◽  
Wirley Gonçalves Assunção ◽  
Claudia Misue Kanno ◽  
Célia Tomiko Matida Hamata Saito ◽  
Juliana Aparecida Delben

Abstract Aim The aim of this report is to describe the restorative treatment of an 18-year-old patient diagnosed with autossomal recessive hypocalcified-hypoplastic amelogenesis imperfect (AI). Background Esthetic and functional rehabilitations in AI cases are challenging and should consider individual aspects, such as age, socioeconomic status, AI type, and intraoral condition. Report AI was diagnosed in an 18-year-old patient. Summary Considering the short length of crowns and roots, patient life expectancy, minimal invasiveness, amount of treatment time required, and lower costs, oral rehabilitation with overdentures provided an adequate functional and esthetic rehabilitation of the patient. Clinical Significance This report demonstrated overdentures to be a viable, relatively inexpensive, and noninvasive treatment choice of a patient with AI with concerns about treatment longevity, invasiveness, cost, esthetics, and long-term maintenance. Citation Assunção WG, Barão VAR, Kanno CM, Saito CTMH, Delben JA. Overdenture as a Restorative Option for Hypocalcified-hypoplastic Amelogenesis imperfecta: A Case Report. J Contemp Dent Pract 2009 May; (10)3:067-073.

2016 ◽  
Vol 31 (1) ◽  
pp. 45
Author(s):  
Dasaiev M. Dutra ◽  
Maria Auxiliadora G do Nascimento ◽  
Maria Sueli Marques Soares

Objective: This article presents a case report of actinic cheilitis with an acute inflammatory process and need for anti- inflammatory treatment.Case Report: Triamcinolone acetonide in Orabase was prescribed 3 times a day for 15 days, and the patient was advised to use sunscreen and hats. After 7 days, there was a significant improvement in the acute phase and the patient was kept under observation.Conclusion: It is emphasized that it is important to intervene in the evolution of the inflammatory process in premalignant lesions in order to prevent its long-term maintenance.


2011 ◽  
Vol 33 (1) ◽  
pp. 82.e1-82.e3 ◽  
Author(s):  
Sandeep Grover ◽  
Munish Aggarwal
Keyword(s):  

2020 ◽  
Vol 14 (Supplement_1) ◽  
pp. S590-S591
Author(s):  
E Sánchez Rodríguez ◽  
F Mesonero Gismero ◽  
A López sanroman

Abstract Background Evaluation of Ustekinumab induction therapy is generally performed at week 16. Our aim was to evaluate if a delayed response may be expected beyond that time. Methods Retrospective study including patients with CD who received Ustekinumab since 1 June 2017 to 1 May 2019. Iv induction dose was based on weight while maintenance was conducted with 90 mg subcutaneous every 8 weeks. Results Twenty-five patients (52% male) were enrolled, of whom 28% (7/25) had ileal, 28(7/25) colonic, 44% (11/25) ileocolonic and 8% (2/25) upper tract involvement. Sixty-eight per cent (17/25) presented an inflammatory, 16% (4/25) a stricturing and 16% (4/25) a penetrating behaviour. Perianal disease was diagnosed in 20% of patients (5/25). All patients 100% (25/25) had previously taken immunosuppressants and 96% (24/25) biological therapy (mean 1.8 ± 0.87 (0–3) per patient): 36% (9/25) one, 36% (9/25) two and 24% (6/25) three agents. Ustekinumab was prescribed for achieving remission in 92% (23/25) of the patients, fistulising disease in 4% (1/25) and for maintenance of remission in the same percentage. Follow-up was 373.16 ± 182.53(59–683) days. Discontinuation rate was 24% (6/25), due to primary failure in 100% (6/6). For those who stopped the drug, average treatment time was 137.17 ± 95.11(61–1320) days whereas that of those who continued was 346.84 ± 192.10(32–669) days. Clinical response was evaluated at week 8, week 14–16, week 22–24 and during long-term maintenance (Table 1). All comparisons were statistically significant (p < 0.05). We recorded Harvey-Bradshaw index(H-B), CRP and faecal calprotectin (FC) before induction with ustekinumab, at weeks 14–16, at weeks 22–24 and during maintenance. Results are presented in Table 2. Conclusion Evaluation of induction effectiveness at week 22–24 may allow to rescue those patients who present a delayed response to UST. During a 373.16 days follow-up, loss of response to Ustekinumab is low.


2014 ◽  
Vol 2014 ◽  
pp. 1-5
Author(s):  
Vaniel Fogli ◽  
Michele Camerini ◽  
Dorina Lauritano ◽  
Francesco Carinci

The implants failure may be caused by micromotion and stress exerted on implants during the phase of bone healing. This concept is especially true in case of implants placed in atrophic ridges. So the primary stabilization and fixation of implants are an important goal that can also allow immediate loading and oral rehabilitation on the same day of surgery. This goal may be achieved thanks to the technique of welding titanium bars on implant abutments. In fact, the procedure can be performed directly in the mouth eliminating possibility of errors or distortions due to impression. This paper describes a case report and the most recent data about long-term success and high predictability of intraorally welded titanium bar in immediate loading implants.


2000 ◽  
Vol 44 (6) ◽  
pp. 1458-1462 ◽  
Author(s):  
Carolyn M. Shoen ◽  
Sharon E. Chase ◽  
Michelle S. DeStefano ◽  
Tami S. Harpster ◽  
Alex J. Chmielewski ◽  
...  

ABSTRACT Previous experiments with rifalazil (RLZ) (also known as KRM-1648) in combination with isoniazid (INH) demonstrated its potential for short-course treatment of Mycobacterium tuberculosisinfection. In this study we investigated the minimum RLZ-INH treatment time required to eradicate M. tuberculosis in a murine model. RLZ-INH treatment for 6 weeks or longer led to a nonculturable state. Groups of mice treated in parallel were killed following an observation period to evaluate regrowth. RLZ-INH treatment for a minimum of 10 weeks was necessary to maintain a nonculturable state through the observation period. Pyrazinamide (PZA) was added to this regimen to determine whether the treatment duration could be further reduced. In this model, the addition of PZA did not shorten the duration of RLZ-INH treatment required to eradicate M. tuberculosis from mice. The addition of PZA reduced the number of mice in which regrowth occurred, although the reduction was not statistically significant.


2015 ◽  
Vol 26 (1) ◽  
pp. 75-78 ◽  
Author(s):  
Bianca Zeponi Fernandes Mello ◽  
Thiago Cruvinel Silva ◽  
Daniela Rios ◽  
Maria Aparecida Andrade Moreira Machado ◽  
Fabrício Pinelli Valarelli ◽  
...  

Ectodermal dysplasia is a rare congenital disease that affects several structures of ectodermal origin. The most commonly related oral characteristics are hypodontia, malformed teeth and underdeveloped alveolar ridges. New alternative treatments are needed due to the failure of the conventional prosthesis retention. This case report outlines the oral rehabilitation treatment of a 9-year-old girl with ectodermal dysplasia. The treatment was performed with conventional prosthesis upon mini-implants. The mini-implants provided prosthetic retention. The patient reported a good adaptation of the dental prosthesis and satisfaction with the treatment. The increased self-esteem improved the socialization skills of the girl. In this case report, use of prosthesis with mini-implants was satisfactory for prosthetic retention. However, clinical studies with long-term follow-up are needed to test the mini-implants as an alternative for oral rehabilitation of children with ectodermal dysplasia.


2017 ◽  
Vol 19 (5) ◽  
pp. 1-4
Author(s):  
A Tikku ◽  
Anil Chandra ◽  
Promila Verma ◽  
Pragya ◽  
Meena Singh

2017 ◽  
Vol 2017 ◽  
pp. 1-13 ◽  
Author(s):  
Stephen N. Housley ◽  
David Wu ◽  
Kimberly Richards ◽  
Samir Belagaje ◽  
Maysam Ghovanloo ◽  
...  

Stroke is a leading cause of long-term disability around the world. Many survivors experience upper extremity (UE) impairment with few rehabilitation opportunities, secondary to a lack of voluntary muscle control. We developed a novel rehabilitation paradigm (TDS-HM) that uses a Tongue Drive System (TDS) to control a UE robotic device (Hand Mentor: HM) while engaging with an interactive user interface. In this study, six stroke survivors with moderate to severe UE impairment completed 15 two-hour sessions of TDS-HM training over five weeks. Participants were instructed to move their paretic arm, with synchronized tongue commands to track a target waveform while using visual feedback to make accurate movements. Following TDS-HM training, significant improvements in tracking performance translated into improvements in the UE portion of the Fugl-Meyer Motor Assessment, range of motion, and all subscores for the Stroke Impact Scale. Regression modeling found daily training time to be a significant predictor of decreases in tracking error, indicating the presence of a potential dose-response relationship. The results of this pilot study indicate that the TDS-HM system can elicit significant improvements in moderate to severely impaired stroke survivors. This pilot study gives preliminary insight into the volume of treatment time required to improve outcomes.


2012 ◽  
Vol 2012 ◽  
pp. 1-8
Author(s):  
Niloufar Khodaeian ◽  
Mahmoud Sabouhi ◽  
Ebrahim Ataei

Amelogenesis imperfecta (AI) has been defined as a group of hereditary enamel defects. It can be characterized by enamel hypoplasia, hypomaturation, or hypocalcification of the teeth. AI may be associated with some other dental and skeletal developmental defects. Restoration for patients with this condition should be oriented toward the functional and esthetic rehabilitation. This clinical report describes the oral rehabilitation of a young patient diagnosed with the hypoplastic type of AI in posterior teeth and hypomatured type of AI in anterior teeth.


Sign in / Sign up

Export Citation Format

Share Document